American Journal of Cardiovascular Drugs

Acknowledgment
pp. 361-362(2)
Author: Adis International Limited,

Effect of Olmesartan Medoxomil on Atherosclerosis: Clinical Implications of the Emerging Evidence
pp. 363-366(4)
Authors: Takai, Shinji; Miyazaki, Mizuo

Intensive Reduction of Low-Density Lipoprotein-Cholesterol: Implications of Recent Trials
pp. 367-371(5)
Author: Hackam, Daniel G.

Role of the Renin-Angiotensin-Aldosterone System in Diastolic Heart Failure: Potential for Pharmacologic Intervention
pp. 373-381(9)
Authors: Bernal, Juan; Pitta, Sridevi R.; Thatai, Deepak

The A-SACT (Achievement in Singapore of Cholesterol Targets) Study in Patients with Coronary Heart Disease
pp. 383-391(9)
Authors: Ho, Kheng-Thye; Chin, Khong-Whee; Ng, Kheng-Siang; Alemao, Evo; Rajagopalan, Srinivasan; Yin, Don

Bedtime Administration of Graded-Release Diltiazem in Patients with Inadequate BP Control: A Tolerability and Efficacy Study
pp. 393-400(8)
Authors: Fitchett, David H.; Casanova, Amparo; Jaffer, Shahin; Tan, Mary; Kornilova, Oksana; Goodman, Shaun G.; Langer, Anatoly

The Impact of Baseline HR and BP on the Tolerability of Carvedilol in the Elderly: The COLA (Carvedilol Open Label Assessment) II Study
pp. 401-405(5)
Authors: Macdonald, Peter S.; Hill, Julie; Krum, Henry

Clopidogrel Bisulfate: In ST-Segment Elevation Myocardial Infarction
pp. 407-414(8)
Authors: Dickie, Jennifer S.; Scott, Lesley J.

Clopidogrel Bisulfate In ST-Segment Elevation Myocardial Infarction: A Viewpoint by Deepak L. Bhatt
pp. 415-416(2)
Author: Bhatt, Deepak L.

Clopidogrel Bisulfate In ST-Segment Elevation Myocardial Infarction: A Viewpoint by Steven R. Steinhubl
pp. 415-416(2)
Author: Steinhubl, Steven R.

Clopidogrel Bisulfate In ST-Segment Elevation Myocardial Infarction: A Viewpoint by Jeffrey W. Moses
pp. 415-416(2)
Author: Moses, Jeffrey W.

Ramipril: A Review of its Use in Preventing Cardiovascular Outcomes in High-Risk Patients
pp. 417-432(16)
Authors: Anderson, Vanessa R.; Perry, Caroline M.; Robinson, Dean M.